Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2025-12-30 @ 2:07 PM
Study NCT ID:
NCT03854903
Status:
COMPLETED
Last Update Posted:
2025-02-06
First Post:
2019-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor
Sponsor:
Georgetown University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-09
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-21
First Submit QC Date:
None
Study First Post Date:
2019-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-05
Last Update Post Date:
2025-02-06
Last Update Post Date Type:
ACTUAL